Blue Hawk Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
- Paid Up Capital ₹ 4.50 Cr
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.80 Cr
- Revenue Growth %
- Profit Growth -8721.62%
- Ebitda -8210.81%
- Net Worth -704.97%
- Total Assets 14006.42%
About Blue Hawk Life Sciences
Blue Hawk Life Sciences Private Limited (BHLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2021 (Three years and three months 4 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹9.80 Cr.
Siva Hosur, Swarajya Kristipati, Borra Krishnaveni, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24110TS2021PTC186540
-
Company No.
119954
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Blue Hawk Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siva Hosur
|
Managing Director | 09-Nov-2021 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Swarajya Kristipati
|
Director | 15-Feb-2023 | Current |
|
Borra Krishnaveni
|
Director | 15-Feb-2023 | Current |
|
Karthik Undar
|
Director | 09-Nov-2021 | Current |
Financial Performance of Blue Hawk Life Sciences.
Blue Hawk Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 8721.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 704.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Hawk Life Sciences?
In 2023, Blue Hawk Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.80 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 9.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2023 | Axis Bank Limited | ₹9.80 Cr | Open |
How Many Employees Work at Blue Hawk Life Sciences?
Blue Hawk Life Sciences has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Hawk Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Hawk Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
